Apex Capital Management - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 151 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.66 and the average weighting 0.8%.

Quarter-by-quarter ownership
Apex Capital Management ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$10,152,000
-31.7%
250,037
+9.2%
0.22%
-32.5%
Q4 2015$14,858,000
-7.9%
228,867
+0.1%
0.33%
-9.0%
Q3 2015$16,137,000
-32.6%
228,601
+6.1%
0.36%
-28.7%
Q2 2015$23,951,000
+43.3%
215,507
+21.6%
0.51%
+29.9%
Q1 2015$16,711,000177,2130.39%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Flagship Ventures 2007 General Partner LLC 1,930,369$118,428,00083.56%
Third Rock Ventures, LLC 3,070,090$188,350,00021.97%
Opaleye Management Inc. 113,500$6,963,225,0005.43%
BB BIOTECH AG 1,890,521$115,983,0004.72%
Eventide Asset Management 431,600$26,479,0003.70%
Atika Capital Management LLC 54,000$3,313,0002.55%
Cormorant Asset Management, LP 100,000$6,135,0001.26%
BRIDGER MANAGEMENT, LLC 220,099$13,503,0000.92%
Ghost Tree Capital, LLC 20,000$1,227,0000.67%
HAMILTON LANE ADVISORS LLC 27,544$1,690,0000.55%
View complete list of AGIOS PHARMACEUTICALS INC shareholders